Specialization
Focus of research
B-cell malignancies
Cellular therapy
-
Risk of thrombosis and bleeding following CAR T-cell therapy: Insights from the Dutch “Follow that CAR!” registry
Ko, A. K., Mutsaers, P. G. N. J., van Kleij, L. M., Vledder, A., Pennings, E. R. A., Spanjaart, A. M., de Boer, J. W., Keijzer, K., Demandt, A. M. P., van Doesum, J. A., van Dorp, S., Jak, M., Kuipers, M. T., van Meerten, T., van der Poel, M. W. M., Vermaat, J. S. P., Leebeek, F. W. G., Kersten, M. J. & Lauw, M. N., Jul 2026, In: HemaSphere. 10, 7, e70433.Research output: Contribution to Journal › Article › Academic › peer-review
-
Risks and benefits for patients with relapsed or refractory diffuse large B-cell lymphoma in early-phase clinical trials: a systematic review and meta-analysis
Spanjaart, A. M., Bakker, M., de Vries, R., Hutten, B. A., van Nieuwenhuijzen, N., Minnema, M. C., Kuipers, M. T. & Kersten, M. J., 1 May 2026, In: The Lancet Haematology. 13, 5, p. e297-e314Research output: Contribution to Journal › Article › Academic › peer-review
-
Navigating Ethical Challenges in CAR-T Treatment
Pennings, E. R. A., Spanjaart, A. M., Schaaphok, A. R., van Maanen, M. A., Tonino, S. H., Kuipers, M. T., Kersten, M. J. & Metselaar, S., 2026, (E-pub ahead of print) In: HEC Forum.Research output: Contribution to Journal › Article › Academic › peer-review
- All publications